KCNA5 Gene Atrial Fibrillation Type 7 NGS Genetic DNA Test
Comprehensive Introduction to Cardiac Genetic Testing
The KCNA5 Gene Atrial Fibrillation Type 7 NGS Genetic DNA Test represents a breakthrough in cardiovascular genetic medicine, offering precise identification of inherited cardiac arrhythmia syndromes. This advanced diagnostic tool specifically targets mutations in the KCNA5 gene, which encodes potassium voltage-gated channel subfamily A member 5—a critical component in cardiac electrical signaling pathways. Understanding your genetic predisposition to atrial fibrillation enables proactive management and personalized treatment strategies that can significantly improve long-term cardiovascular health outcomes.
What This Test Measures and Detects
Our comprehensive NGS-based analysis examines the complete coding region of the KCNA5 gene to identify:
- Pathogenic variants associated with familial atrial fibrillation type 7
- Single nucleotide polymorphisms affecting potassium channel function
- Insertion/deletion mutations disrupting normal cardiac rhythm regulation
- Genetic markers predictive of arrhythmia susceptibility
- Inherited mutations passed through family lineages
Advanced Next Generation Sequencing Technology
Utilizing cutting-edge NGS methodology, our test provides unparalleled accuracy in detecting even rare genetic variants that conventional methods might miss. This comprehensive approach ensures complete coverage of the KCNA5 gene, delivering reliable results for informed clinical decision-making.
Who Should Consider This Genetic Test
This specialized cardiac genetic test is particularly recommended for individuals experiencing:
- Unexplained palpitations or irregular heartbeats
- Family history of atrial fibrillation or sudden cardiac death
- Early-onset atrial fibrillation (before age 60)
- Recurrent syncope or dizziness of unknown origin
- Resistance to conventional anti-arrhythmic medications
- Multiple family members with cardiac rhythm disorders
- Unexplained stroke or thromboembolic events
Clinical Indications and Risk Factors
Patients with documented atrial fibrillation who have first-degree relatives with similar conditions should strongly consider genetic testing. Additionally, individuals with unexplained cardiac symptoms despite normal routine cardiac evaluations may benefit from this comprehensive genetic analysis.
Significant Benefits of Genetic Testing
Undergoing the KCNA5 gene test provides numerous advantages for cardiac care management:
- Personalized Treatment Planning: Results guide targeted anti-arrhythmic therapy selection
- Family Risk Assessment: Identifies at-risk relatives for preventive monitoring
- Early Intervention Opportunities: Enables proactive management before symptom onset
- Improved Prognostic Accuracy: Enhances prediction of disease progression and complications
- Reproductive Counseling: Provides information for family planning decisions
- Reduced Diagnostic Uncertainty: Offers definitive answers for unexplained cardiac symptoms
Understanding Your Test Results
Our comprehensive genetic counseling services help you interpret your results effectively:
Positive Result Interpretation
A positive result indicates the presence of a pathogenic KCNA5 gene variant associated with atrial fibrillation susceptibility. This finding enables:
- Implementation of targeted surveillance protocols
- Personalized medication selection based on genetic profile
- Family member testing recommendations
- Lifestyle modification guidance
Negative Result Significance
A negative result suggests the absence of known pathogenic KCNA5 variants, though continued clinical monitoring may still be recommended based on individual risk factors and family history.
Variant of Uncertain Significance
Some genetic changes may require additional family studies or research correlation to determine clinical significance. Our genetic counselors provide ongoing support for result interpretation updates.
Test Pricing and Availability
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Testing Process Details
- Turnaround Time: 3 to 4 Weeks
- Sample Type: Blood, Extracted DNA, or One Drop Blood on FTA Card
- Pre-test Requirements: Complete Clinical History and Genetic Counseling Session
- Specialty: Cardiology and Genetics
- Methodology: Next Generation Sequencing (NGS) Technology
Nationwide Testing Accessibility
We maintain comprehensive testing facilities across all major United States metropolitan areas, including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network ensures convenient access to advanced cardiac genetic testing regardless of your location.
Take Control of Your Cardiac Health Today
Don’t let uncertainty about your genetic cardiac risk factors compromise your health and quality of life. Our specialized KCNA5 gene testing provides the clarity needed for informed medical decisions and personalized cardiac care. Schedule your genetic counseling session and testing appointment today to begin your journey toward comprehensive cardiac health management.
Call or WhatsApp us now at +1(267) 388-9828 to book your KCNA5 Gene Atrial Fibrillation Type 7 NGS Genetic DNA Test and take the first step toward personalized cardiac care.
